Author:
Kushwah Varun,Münzer Juliana,Feenstra Verena,Mohr Stefan,Paudel Amrit
Abstract
AbstractThe manufacturing of biopharmaceutical drug solutions can involve close contact with various polymeric components, including common filter membranes. Potential leachable substances from filters may interact with the protein and thereby increase the structural damage and aggregation. The main aim of the study deals with the assessment of extractable and leachable (E/L) from different filters and the potential effect of E/Ls on protein (human granulocyte-colony stimulating factor (rh-GCSF) stability. The present study examines the E/L profile of five different polymeric filter membranes using various chromatographic techniques including LC–MS and GC–MS. In order to investigate their effect on protein stability, G-CSF (human granulocyte colony-stimulating factor) formulations were spiked with filter leachable stock solutions at two different pH levels. The spiked formulations were further analyzed with respect to their aggregation behavior. The results demonstrated a higher E/L content in the case of polyamide (PA), polycarbonate (PC), and polyethersulfone (PES) filters as compared to the polytetrafluoroethylene (PTFE) and regenerative cellulose (RC) filter materials. The E/L from RC and PES was found surface-active, whereas E/L from PA and RC significantly altered the particle size/structure resulting in the aggregation of proteins. Furthermore, bisphenol A was found to be one of the E/L substances from PC filters and can impose significant health problems when administered along with pharmaceutical products. The present study reports a qualitative rank ordering of the filter membranes in terms of their propensity to generate E/Ls and thus can be helpful in selecting a suitable membrane filter.
Funder
Graz University of Technology
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference47 articles.
1. Jenke DR, et al. Accumulation of extractables in buffer solutions from a polyolefin plastic container. Int J Pharm. Jun. 2005;297(1–2):120–33. https://doi.org/10.1016/j.ijpharm.2005.03.010.
2. Behme S. Manufacturing of pharmaceutical proteins: from technology to economy. John Wiley & Sons; 2021. https://www.wiley.com/en-us/Manufacturing+of+Pharmaceutical+Proteins%3A+From+Technology+to+Economy%2C+3rd+Edition-p-9783527833801.
3. Akers MJ. Sterile drug products: formulation, packaging, manufacturing and quality. CRC Press; 2016. https://www.taylorfrancis.com/books/mono/10.3109/9781420020564/sterile-drug-products-michael-akers.
4. The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use Committee for Proprietary Medicinal Products (cpmp) Decision Trees for the Selection of Sterilisation Methods Decision Trees for the Selection of Sterilisat. 1997. Available: http://www.eudra.org/emea.html. Accessed 16 July 2021.
5. Committee for Medicinal Products for Human use (CHMP) Committee for Medicinal Products for Veterinary use (CVMP) Guideline on the sterilisation of the medicinal product, active substance, excipient and primary container. 2019, Available: www.ema.europa.eu/contactTelephone+31. Accessed 16 July 2021.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献